The antiviral drug tecovirimat has been approved in Europe to treat mpox, on the basis of animal studies. But a clinical ...

Researchers have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions our DNA, which make up the vast majority of the human genome.